FULC - Fulcrum Therapeutics, Inc.
NEXT EARNINGS:
Feb 24, 2026
(today)
EPS Est: $-0.31
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.57
DETAILS
HIGH:
$25.00
LOW:
$10.00
MEDIAN:
$23.00
CONSENSUS:
$20.57
UPSIDE:
139.74%
Market Cap:
464.28M
Volume:
4,152,290
Avg Volume:
1,332,273
52 Week Range:
2.315-15.74
Sector:
Healthcare
Industry:
Biotechnology
Beta:
3.18
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
45
IPO Date:
2019-07-18
EPS (TTM):
-1.18
P/E Ratio:
-9.57
Revenue (TTM):
N/A
Total Assets:
366.28M
Total Debt:
6.44M
Cash & Equiv:
197.53M
Rev Growth (5Y):
73.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
N/A
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $-0.32 | $-0.31 | -3.5% | — | — | — |
| 2025-10-29 | $-0.31 | $-0.29 | -6.9% | — | — | — |
| 2025-07-29 | $-0.28 | $-0.29 | +3.4% | — | — | — |
| 2025-05-01 | $-0.28 | $-0.29 | +3.4% | — | — | — |
| 2025-02-25 | $-0.31 | $-0.28 | -10.7% | — | — | — |
| 2024-11-13 | $-0.35 | $-0.40 | +12.5% | — | — | — |
| 2024-07-31 | $0.87 | $0.01 | +7060.5% | $80.0M | $14.8M | +439.9% |
| 2024-05-13 | $-0.43 | $-0.44 | +2.3% | — | $36.5M | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 80.00M | 2.81M | 6.34M | 19.16M | 8.82M | 0 | 0 | 0 |
| Net Income | (74.88M) | (9.72M) | (97.33M) | (109.87M) | (80.85M) | (70.82M) | (82.68M) | (32.59M) | (22.96M) |
| EPS | -1.18 | -0.16 | -1.59 | -2.35 | -2.22 | -2.70 | -3.49 | -1.92 | -1.36 |
| Total Assets | 366.28M | 260.72M | 257.69M | 226.69M | 235.00M | 129.58M | 110.44M | 85.77M | 4.34M |
| Total Debt | 6.44M | 8.63M | 10.82M | 13.42M | 0 | 17,000 | 50,000 | 46,000 | 34.59M |
| Cash & Equivalents | 197.53M | 58.21M | 25.56M | 35.10M | 35.41M | 57.05M | 96.71M | 72.80M | 407,000 |
| Operating Cash Flow | (60.06M) | (2.22M) | (90.97M) | (97.05M) | (78.48M) | (53.66M) | (39.48M) | (22.56M) | (20.07M) |
| Free Cash Flow | (60.38M) | (2.50M) | (91.47M) | (99.01M) | (80.19M) | (55.00M) | (40.34M) | (31.54M) | (21.98M) |
| FCF per Share | -0.95 | -0.04 | -1.49 | -2.20 | -2.27 | -2.17 | -1.78 | -1.86 | -1.30 |
| Book Value | 349.00M | 243.03M | 235.19M | 198.94M | 211.54M | 95.18M | 87.15M | 76.00M | 1.32M |
| Cash & ST Investments | 352.31M | 241.02M | 236.22M | 202.92M | 218.16M | 112.91M | 96.71M | 72.80M | 407,000 |
| ROC Equity | -0.21 | -0.04 | -0.41 | -0.55 | -0.38 | -0.74 | -0.95 | -0.43 | -17.37 |